U.K. regulatory fees to rise
This article was originally published in The Gray Sheet
U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) proposes to raise fees related to Notified Body and Conformity Assessment Body device regulatory activity on April 1, 2010. The move will raise overall fee income by "just over 1%" to about £351,000 from £347,000, according to the agency. Comments will be accepted until Jan. 8, 2010
You may also be interested in...
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.